4 April 2018
Taking a standard prostate cancer drug with low-fat food, instead of on empty stomach, could boost outcome and lower drug costs by 75% for patients with reduced daily dosage
The multi-site study with United States is part of the National University Cancer Institute, Singapore’s (NCIS) larger efforts to address escalating costs of oncology drug treatment with research that focus on high quality and high value care. Read more...
21 March 2018
NCIS to Raise Cancer Awareness through 10,000 Ribbon Singapore Book of Records Attempt
On 24 March 2018, the National University Cancer Institute, Singapore (NCIS) will attempt to set a Singapore Book of Records (SBR) by collecting 10,000 cancer awareness ribbons, which will be the largest collection in Singapore. The ribbons will be a symbol of support for those who were lost to cancer, survived cancer and are currently battling cancer. The ribbon collection will be made alongside NCIS’ Signature 10th anniversary public awareness event held at Canopy@JLink, which is located at Jurong East. Members of the public are encouraged to pin a ribbon and pledge to go for cancer screening within a year. Professor Chng Wee Joo, Director of NCIS, will be gracing the milestone event. “The pledge of 10,000 ribbons, is a way for us to show our support to everyone in the fight against cancer, be it the patients, their friends or their families,” says Professor Chng. “Cancer continues to be the leading cause of death in Singapore. Therefore, it is important to not only educate the public on cancer, but to also pledge to ourselves and our loved ones to go for early cancer screening.” Read more...
29 July 2018 (Lianhe Zaobao)
Dr Noreen Chan from NCIS was one of the doctors interviewed on end-of-life care. She shared that the focus of our medical system is usually the patient’s ‘body’, neglecting the spiritual and emotional needs. She said many times the medication is not in the bottle but in relationships, in positive words and encouragement.” She added that many times patients do not need the many medical tests and treatments. Conversations are more important and is the beginning of providing quality care. Read more...
16 July 2018 (The Straits Times)
Precision medicine gives cancer patients hope
A programme by the National University Cancer Institute Singapore (NCIS) is helping to match cancer patients with certain genetic profiles to early-phase clinical trials of new drugs. More than 200 patients comprising Singapore residents and foreigners have agreed to undergo genetic testing, under the expanded Integrated Molecular Analysis of Cancer Programme, according to Dr David Tan, consultant at NCIS' Department of Haematology-Oncology, and the lead investigator. The NCIS has been working with molecular insights company Foundation Medicine, a subsidiary of Roche, since May last year to screen patients' tumours for abnormalities in 315 genes to match them to suitable trials.Dr Tan added that the programme gives patients access to drugs which are not yet on the market, and provides them with targeted treatment. Read more...